Rankings
▼
Calendar
EYPT Q2 2016 Earnings — EyePoint Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
EYPT
EyePoint Pharmaceuticals, Inc.
$1B
Q2 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$304,000
Gross Profit
-$4M
-1250.0% margin
Operating Income
-$6M
-2123.7% margin
Net Income
-$6M
-2101.0% margin
EPS (Diluted)
$-1.87
QoQ Revenue Growth
-6.2%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$614,000
Balance Sheet
Total Assets
$32M
Total Liabilities
$11M
Stockholders' Equity
$21M
Cash & Equivalents
$15M
← FY 2016
All Quarters
Q3 2016 →
